0 CHECKOUT

PRODUCT FILTERS

CATEGORIES

  • 2
  • 1

PRICE

1
3
3
3

PUBLISHED

0
3
3
3

PRODUCT TYPE

Search for: "Stragen Pharma S.A-Company Report"

Treatment of Multiple Myeloma - Patent Overview in the years 2011 - 2016

Multiple myeloma is cancer formed by malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. In multiple myeloma, a type of white blood...

Published:  June 2016
Price: 

Treatment of Chronic Myelogenous Leukemia (CML) - Patent Overview in the years 2011 - 2016

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in certain blood-forming cells of the bone marrow. In CML, a genetic change takes place in...

Published:  June 2016
Price: 

Treatment of Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) - Patent Overview in the years 2011 - 2016

Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs) account for less than 5% of all pancreatic tumors. They may be benign or malignant and they tend to grow slower than exocrine tumors. They...

Published:  June 2016
Price: 
Loading Indicator

Our Clients

  • Ikea Systems B.V.
  • GlaxoSmithKline PLC
  • BT Group PLC.
  • Philips N.V.
  • BSH Home Appliances Ltd
  • Foreign & Commonwealth Office